Association of psoriasis and systemic lupus erythematosus and mediation effects of tumor necrosis factor-α inhibitors: A cross-sectional study in the All of Us Research Program

J Am Acad Dermatol. 2024 Jan;90(1):184-187. doi: 10.1016/j.jaad.2023.09.028. Epub 2023 Sep 19.

Authors

Gloria F Chen¹, Suyeon Hong¹, Sarika M Ramachandran², Jeff R Gehlhausen², Jeffrey M Cohen³

Affiliations

¹ Yale School of Medicine, New Haven, Connecticut.
² Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
³ Department of Dermatology, Yale School of Medicine, New Haven, Connecticut; Section of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, Connecticut. Electronic address: jeffrey.m.cohen@yale.edu.

PMID: 37734665
DOI: 10.1016/j.jaad.2023.09.028

No abstract available

MeSH terms

Cross-Sectional Studies
Humans
Immunologic Factors
Lupus Erythematosus, Systemic* / drug therapy
Lupus Erythematosus, Systemic* / epidemiology
Population Health*
Psoriasis* / drug therapy
Psoriasis* / epidemiology
Tumor Necrosis Factor-alpha

Substances

Tumor Necrosis Factor-alpha
Immunologic Factors